NEW YORK (360Dx) – The American Society of Clinical Oncology and the College of American Pathologists have updated their guidelines for human epidermal growth factor receptor 2 (HER2) testing in breast cancer. The guidelines, first released in 2007, were last updated in 2013.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.